DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 54 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $190,000 | +53.2% | 33,000 | -15.4% | 0.11% | +43.6% |
| Q2 2017 | $124,000 | +169.6% | 39,000 | +188.9% | 0.08% | +169.0% |
| Q1 2017 | $46,000 | -63.5% | 13,500 | -69.1% | 0.03% | -63.3% |
| Q4 2016 | $126,000 | +34.0% | 43,719 | +173.2% | 0.08% | +31.7% |
| Q3 2016 | $94,000 | +56.7% | 16,000 | -20.0% | 0.06% | +53.8% |
| Q2 2016 | $60,000 | -85.4% | 20,000 | -20.0% | 0.04% | -84.5% |
| Q4 2014 | $412,000 | – | 25,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |